Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection.
about
The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cellsDendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?Natural killer cells promote early CD8 T cell responses against cytomegalovirusInsufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cellsBoosting vaccine efficacy the natural (killer) wayγδ T Cells in HIV Disease: Past, Present, and FutureHIV-1 and hijacking of the host immune system: the current scenario.Self MHC class I-licensed NK cells enhance adaptive CD8 T-cell viral immunity.MHC class I D(k) expression in hematopoietic and nonhematopoietic cells confers natural killer cell resistance to murine cytomegalovirusLysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.HMGB1-dependent triggering of HIV-1 replication and persistence in dendritic cells as a consequence of NK-DC cross-talkEscape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk--a pivotal role of HMGB1.Dendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors.Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection.Plasmacytoid dendritic cells in HIV infection: striking a delicate balance.T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines.Loss of NK stimulatory capacity by plasmacytoid and monocyte-derived DC but not myeloid DC in HIV-1 infected patients.Accessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection.Association of activating KIR copy number variation of NK cells with containment of SIV replication in rhesus monkeys.Innate immune activation in primary HIV-1 infection.NK cells and their ability to modulate T cells during virus infectionsNatural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral ActivityMutiny or scrutiny: NK cell modulation of DC function in HIV-1 infection.Involvement of CD226+ NK cells in immunopathogenesis of systemic lupus erythematosusAlterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adultsDefective natural killer cell anti-viral capacity in paediatric HBV infection.Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C VirusHIV-1-induced impairment of dendritic cell cross talk with γδ T lymphocytes.HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cellsHIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway.Innate immunity in acute HIV-1 infectionLow CD1c + myeloid dendritic cell counts correlated with a high risk of rapid disease progression during early HIV-1 infection.DCs and NK cells: critical effectors in the immune response to HIV-1.Restoration of TLR3-activated myeloid dendritic cell activity leads to improved natural killer cell function in chronic hepatitis B virus infectionInterferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo.'Emergency exit' of bone-marrow-resident CD34(+)DNAM-1(bright)CXCR4(+)-committed lymphoid precursors during chronic infection and inflammationDifferential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes.
P2860
Q21144323-9CAB5E28-682E-4510-81C5-100381C6AADFQ27010312-7A76D311-5D18-45F6-81E2-2B26C0E3635DQ27319836-BA5F8A0A-391E-46B0-9BD2-7CA2D3CE789AQ28068375-8B378CCB-EF81-4C62-8468-5CB2458F0326Q28084474-59D73A5F-9211-4C65-BEF8-DCBE6C494F27Q28084822-6C273081-FC6B-4340-8C80-BBD376C97A63Q30248405-287B905C-9099-49DF-94A5-90F10FE5756AQ30426938-BF5CD5C7-E955-4C53-BB43-2BECCCF8D159Q30434183-40B5C6B4-25C6-4FC1-83D6-E7438F2E81B7Q30845033-92D88653-7363-4D19-94C2-C32DD7B3AD0CQ33381657-D6D1FA1A-DE85-43D3-B93D-71512B1CAEAFQ33564423-378EC1F2-6516-4D39-A113-24392BCE96FFQ33604765-4C8C949D-F6C3-47F6-93D7-FC5B1BEEAB79Q33654658-7A25DBF6-B14C-4DF5-98EE-5D1FF2CB303BQ33741498-3E85D21A-D523-49EA-8476-AC3D3ECCE293Q33805319-F3C9545C-051D-47C2-A531-8735CB66D2A6Q33807523-3F4BA88F-9EDF-40B4-B025-0E1D53AF0630Q33847612-F5F5583A-D9FF-4865-81F8-BBFDEFF88041Q34020126-63F7D3AB-8C2D-424C-8749-44C051AE6B72Q34109760-711F9F0F-CBEF-41DF-A6B8-26980F54F1CBQ34155538-0C458F66-7CBF-420A-962F-7A58A1B5D479Q34700499-CA90FD0B-C004-4773-9B40-6D8648697150Q34741864-FCFF8B5A-3B87-4B25-838E-68461A2E025DQ34774226-93D8BF38-A901-4799-ABF6-DC6EF39C6FA9Q34785742-7B85AE37-8369-4103-9655-41BE39D5D6DBQ34959053-97888015-1232-421C-BB2A-2D8C1954CB21Q34989378-9DE66250-6B12-4D1F-9E9F-21A5E49BC6B7Q35034531-91EF323C-B7D3-4856-9A76-A287C5AE8050Q35111394-D35104BD-3E49-47ED-A437-1B9ACD04C312Q35158581-45E4996D-B2C5-4758-A4E3-FB54663819B6Q35488947-5F2BA6CF-64DF-46EB-A6D2-5C039A7BFE91Q35657400-E0FA0280-2128-4AC7-8896-6E49F455CA52Q35668299-3FC5ADF6-CDCB-4162-8AAA-9D6EF44C3703Q35696991-E6CA1768-0319-486C-88F2-F53424AA9AEFQ35749350-8DCBD060-8F52-433E-BAE0-CED2B78552FBQ35752667-C4BE0320-717F-49BF-A9FE-7FD15B2C75F5Q35868037-85235CC4-3549-4854-8C1E-C079118D472FQ36093940-B13D734D-CE84-435A-924A-7B31B8CC3779Q36145878-017B6B92-7071-4A68-9794-CF2F259BD294Q36229197-4F293FF6-22D2-45AD-8E36-C4EC182F6A29
P2860
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Characterization of the defect ...... itic cells in HIV-1 infection.
@ast
Characterization of the defect ...... itic cells in HIV-1 infection.
@en
type
label
Characterization of the defect ...... itic cells in HIV-1 infection.
@ast
Characterization of the defect ...... itic cells in HIV-1 infection.
@en
prefLabel
Characterization of the defect ...... itic cells in HIV-1 infection.
@ast
Characterization of the defect ...... itic cells in HIV-1 infection.
@en
P2093
P2860
P356
P1476
Characterization of the defect ...... itic cells in HIV-1 infection.
@en
P2093
Alessandro Moretta
Andrea La Sala
Annahita Farschi
Audrey Kinter
Colin Kovacs
Daniela Pende
Dean Follmann
Emanuela Marcenaro
Gabriella Lombardo
Manuela Fogli
P2860
P304
P356
10.1084/JEM.20060894
P407
P577
2006-09-25T00:00:00Z